IntoCell Inc
KOSDAQ:287840
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
IntoCell Inc
KOSDAQ:287840
|
KR |
|
I
|
Investigator Silver Ltd
F:VOP
|
AU |
|
W
|
Walrus Pump Co Ltd
TPEX:6982
|
TW |
|
SalesCloser Technologies Ltd
OTC:SCTLF
|
CA |
|
Industrial & Infrastructure Fund Investment Corp
TSE:3249
|
JP |
|
M
|
MachTen Inc
OTC:MACT
|
US |
|
Casa Minerals Inc
F:0CM
|
CA |
|
Anatara Lifesciences Ltd
ASX:ANR
|
AU |
|
B
|
Bion Environmental Technologies Inc
OTC:BNET
|
US |
|
R
|
RingNet Co Ltd
KOSDAQ:042500
|
KR |
Bankruptcy Probability
IntoCell Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Financial Position
| Jun 30, 2026 | 17.6B |
| Mar 31, 2026 | 19.7B |
| Dec 31, 2025 | 23.1B |
| Sep 30, 2025 | 22.4B |
| Jun 30, 2026 | 1.8B |
| Mar 31, 2026 | 1.8B |
| Dec 31, 2025 | 1.8B |
| Sep 30, 2025 | 1.8B |
| Jun 30, 2026 | 176m |
| Mar 31, 2026 | 10.2B |
| Dec 31, 2025 | 10.2B |
| Sep 30, 2025 | 10.2B |
Solvency Ratios
Solvency Ratios Comparison
IntoCell Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| KR |
I
|
IntoCell Inc
KOSDAQ:287840
|
260.2B KRW |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
481.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
220.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
182.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
127.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
78.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
76.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
88B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
56.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
45.6B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
40.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
IntoCell Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, IntoCell Inc has total debt of 176m KRW. This includes both short-term (0 KRW) and long-term (176m KRW) debt.
You can find a full breakdown on its Balance Sheet.